NaBGL1_candidate_BGLU42 is a lower-confidence historical GH1 beta-glucosidase comparator that was launched before the current mapping pass. The pathway paper secures beta-GD/NicGH biology at the family level, but the newer sequence-backed mapping now favors the BGLU18 pair rather than BGLU42 as the best current NICAT orthology anchors to the nicotine-pathway hydrolases.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds | IEA GO_REF:0000002 | MODIFY | Summary: This parent hydrolase term should be replaced by the more specific beta-glucosidase term. Reason: GO:0008422 already captures the relevant glycosidase specificity for this GH1 family enzyme. Proposed replacements: beta-glucosidase activity |
| GO:0005975 carbohydrate metabolic process | IEA GO_REF:0000002 | MARK AS OVER ANNOTATED | Summary: This broad process term is true in a generic sense but not the informative curation takeaway. Reason: The evidence that remains secure for this accession is generic GH1 beta-glucosidase chemistry rather than a specific pathway assignment. |
| GO:0008422 beta-glucosidase activity | IEA GO_REF:0000120 | ACCEPT | Summary: This is an appropriate core molecular-function annotation. Reason: UniProt identifies terminal beta-D-glucoside hydrolysis chemistry for this GH1 enzyme. Supporting Evidence: file:NICAT/NaBGL1_candidate_BGLU42/NaBGL1_candidate_BGLU42-uniprot.txt Reaction=Hydrolysis of terminal, non-reducing beta-D-glucosyl residues with release of beta-D-glucose.; EC=3.2.1.21; |
| GO:0009821 alkaloid biosynthetic process | IEA GO_REF:0000117 | REMOVE | Summary: This pathway-process assignment is no longer strong enough for this specific accession. Reason: The current mapping work indicates that BGLU42 is not the best orthology anchor to the specialized beta-GD pathway enzymes. |
| GO:0030245 cellulose catabolic process | IEA GO_REF:0000002 | REMOVE | Summary: This appears to be an over-transfer from the broad GH1 family and should be removed. Reason: This appears to be a generic GH1 family overcall rather than a reviewed biological role for BGLU42. |
Loading supporting contentβ¦
Download this section (compressed HTML)Q: Is BGLU42 completely outside the nicotine pathway, or does it retain any partial redundancy with the BGLU18 candidates?
Q: What substrates distinguish BGLU42 from the now-preferred BGLU18_6 and BGLU18_1 paralogs?
Experiment: Compare BGLU42 directly against BGLU18_6 and BGLU18_1 using nicotine-pathway glucosides and generic GH1 substrates.
Hypothesis: BGLU42 will show a substrate profile distinct from the preferred BGLU18 pathway candidates.
Type: biochemical substrate-specificity assay
Experiment: Disrupt BGLU42 alone and in combination with the BGLU18 candidates to test for any hidden redundancy in nicotine accumulation phenotypes.
Hypothesis: BGLU42 loss alone will have weaker nicotine-pathway effects than disruption of the BGLU18 candidates.
Type: genetic perturbation plus metabolite profiling
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)